ArticleBMC medical informatics and decision making2026
Design and evaluation of an automated pediatric acute lymphoblastic leukemia registry from clinical data warehouses.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundReal-world data (RWD)–based pediatric acute lymphoblastic leukemia (ALL) registries often face scalability and reliability limits owing to manual data entry and inter-institutional heterogeneity. We evaluated the feasibility of building an automated, high-quality registry using electronic medical records (EMR) and clinical data warehouses (CDWs) to quantitatively assess the Pediatric ALL Automated Registry (PeARL) for (1) automatic extractability (ADE) (2), data quality, and (3) multicenter applicability.
methodsIn this study, we used CDWs to identify patients aged < 18 years with ALL (ICD-10 C91.0) who visited Seoul National University Hospital (SNUH) and the Catholic Medical Center (CMC). between 1990 and 2023. An automated extraction pipeline applied standard mapping, multivariate transformations, and rule-based natural language processing (NLP). Key variables were selected using the Medical Information Standards for Hematologic Cancer. Data quality was evaluated based on 228 rules across five dimensions (completeness, validity, accuracy, uniqueness, and consistency) based on DQ4HEALTH; error rates, defined as the proportion of data elements violating these rules, were calculated before and after quality management.
resultsOverall, 1,609 patients were included (CMC 946; SNUH 663). ADE for key variables was 89.7% at SNUH and 75.0% at CMC; most automations were single-field transformations (SNUH 61.8%; CMC 84.7%), with multivariate transformations and rule-based NLP addressing complex elements. Initial overall error rates were 1.858% (SNUH) and 0.129% (CMC), decreasing to 0.001% at both institutions after quality processes. Differences in CDW structure required additional preprocessing for laboratory and transplant variables, but harmonization was achieved via standardized table specifications and cross-site review.
conclusionsPeARL integrated standardized mapping, multivariate transformations, and rule-based NLP to enable large-scale automation of a pediatric ALL registry, achieving a 0.001% overall error rate under DQ4HEALTH-based quality management. This clinically guided, standardized framework enables reproducible implementation and scalable automation of pediatric ALL registry construction, supporting multicenter research and the generation of regulatory-grade real-world evidence. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.